PRP STRUCTURE AND POLVOXOMETALATES

PRP 结构和多氧金属盐

基本信息

项目摘要

Program Director/Principal Investigator (Last, First, Middle): Prusiner, Stanley/Long, Jeffrey (Project 1) PROJECT SUMMARY (See instructions): The phosphotungstate anion (PTA) binds specifically to the infectious isoform of the prion protein (PrPSc), but not to its cellular precursor (PrPc). Although PTA is now widely used to precipitate and purify PrPSc, the molecular details and the mechanism of this interaction are not understood. We have observed that the interaction with PTA influences the quaternary structure of PrPSc and its N-terminally truncated form, PrP 27- 30. PTA is.a polyoxometalate (POM), an inorganic metal oxide cluster with a rigid polyhedral structure. POMs are a large family of compounds displaying substantial variations in chemical composition, size, shape, and charge density. We hypothesize that the binding between POMs and PrPSc can be manipulated by changing the chemical composition of the POM, thereby influencing its size, shape, and charge. In order to gain insights into the conformational selectivity of the POM-PrPSc interaction, we plan to investigate the structure, stoichiometry, and speciation of the bound POMs through NMR and infrared spectroscopy. In addition, we plan to use POMs as tools to modify the aggregation properties of PrP50 with the aim of producing higher-quality two-dimensional crystals and amyloidfibrils for structural analyses. The quaternary structure of the POM-prion aggregates will be analyzed by electron microscopy and scanning probe microscopy. In contrast, some larger POMs fail to precipitate PrPSc, and instead dissociate PrPSc aggregates. This unexpected property will be exploited to develop a solubilization protocol for infectious, native PrPSc. Different biophysical properties will be used as solubilization criteria. Bioassays will be utilized extensively to test whether solubilized forms of PrPSc remain infectious. A soluble and homogeneous preparation of PrPSc ^ c would enable numerous structural studies. The affinity of the various POMs for PrP will be analyzed by isothermal titration calorimetry (ITC). ITC allows determination of the stoichiometry, binding constant(Kg), reaction enthalpy (AH), and the standard free energy of binding (AG). RELEVANCE (See instructions): Determining the reaction parameters for the PrPSc¿POM complex formation should facilitate the structural understanding of the interaction between POMs and PrPSc, aid in the selection of new POMs with favorable properties, and enable more rational decisions about the synthesis of additional POMs. So far, relatively few POMs, based on tungsten and molybdenum with selected heteroatoms, have been explored. A wide variety of POM species remain to be tested, including water-soluble POMs based upon vanadium and niobium. PROJECT/
项目主任/首席调查员(最后、第一、中间):普鲁塞纳、斯坦利/朗、杰弗里(项目1) 项目总结(见说明): 磷钨酸盐阴离子(PTA)与传染性蛋白亚型(PrPSc)特异结合,但 而不是它的细胞前体(PrPC)。虽然PTA现在被广泛用于沉淀和纯化PrPSc,但 这种相互作用的分子细节和机制尚不清楚。我们观察到, 与PTA的相互作用影响PrPSc的四元结构及其N-末端截断形式PrP 27- 30.PTA是一种多金属氧酸盐(POM),是一种具有刚性多面体结构的无机金属氧化物簇合物。 POMS是一大类化合物,在化学成分、大小、 形状和电荷密度。我们假设POMS和PrPSc之间的结合是可以操纵的 通过改变POM的化学成分,从而影响其大小、形状和电荷。按顺序 为了深入了解POM-PrPSc相互作用的构象选择性,我们计划研究 通过核磁共振和红外光谱对结合的多金属有机化合物的结构、化学计量和形态进行了研究。在……里面 此外,我们计划使用POMS作为工具来修改PrP50的聚合属性,目的是 生产用于结构分析的更高质量的二维晶体和淀粉原纤维。第四纪 将用电子显微镜和扫描探针分析POM-Prion聚集体的结构 显微镜。相反,一些较大的POM不能沉淀PrPSc,而是解离PrPSc聚集体。 这一意想不到的特性将被利用来开发具有传染性的天然PrPSc的增溶方案。 不同的生物物理性质将被用作增溶标准。生物检测将被广泛应用于 测试溶解形式的PrPSc是否仍具有传染性。一种可溶性均一的PrPSc制备方法 ^c 将使大量的结构研究成为可能。各种POM对PrP的亲和力将通过以下方式分析 等温滴定热法(ITC)。ITC允许测定化学计量比、结合常数(公斤)、 反应热(AH)和标准结合自由能(AG)。 相关性(请参阅说明): 确定PrPSc?POM络合物形成的反应参数应有助于结构 了解POMS和PrPSc之间的相互作用,帮助选择具有有利条件的新POMS 属性,并使关于合成其他POM的更合理的决策。到目前为止,相对较少的 探索了以钨和钼为基础,具有选定的杂原子的多金属有机化合物。种类繁多 多金属有机化合物的种类仍有待测试,包括以钒和铌为基础的水溶性多金属有机化合物。 项目/

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey Long其他文献

Jeffrey Long的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey Long', 18)}}的其他基金

PRP STRUCTURE AND POLVOXOMETALATES
PRP 结构和多氧金属盐
  • 批准号:
    7638096
  • 财政年份:
    2009
  • 资助金额:
    $ 24.81万
  • 项目类别:
PRP STRUCTURE AND POLVOXOMETALATES
PRP 结构和多氧金属盐
  • 批准号:
    8374611
  • 财政年份:
  • 资助金额:
    $ 24.81万
  • 项目类别:
PRP STRUCTURE AND POLVOXOMETALATES
PRP 结构和多氧金属盐
  • 批准号:
    8215258
  • 财政年份:
  • 资助金额:
    $ 24.81万
  • 项目类别:
PRP STRUCTURE AND POLVOXOMETALATES
PRP 结构和多氧金属盐
  • 批准号:
    8429415
  • 财政年份:
  • 资助金额:
    $ 24.81万
  • 项目类别:

相似海外基金

Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
  • 批准号:
    24K10522
  • 财政年份:
    2024
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Two Dimensions of Physiological and Pathological Activities of Synuclein Amyloid Fibrils
突触核蛋白淀粉样原纤维的二维生理病理活性
  • 批准号:
    23K18255
  • 财政年份:
    2023
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Structural basis of the structural development of amyloid fibrils via the prefibrillar intermediates revealed by cryo-electron microscopy
冷冻电子显微镜揭示的前原纤维中间体淀粉样原纤维结构发育的结构基础
  • 批准号:
    22K03555
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An integrated computational and experimental platform for beta-lactoglobulin amyloid fibrils molecular simulations
用于β-乳球蛋白淀粉样原纤维分子模拟的集成计算和实验平台
  • 批准号:
    577692-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Canadian Graduate Scholarships Foreign Study Supplements
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
  • 批准号:
    10379970
  • 财政年份:
    2020
  • 资助金额:
    $ 24.81万
  • 项目类别:
Study on irradiation effect of terahertz free electron laser on amyloid fibrils
太赫兹自由电子激光对淀粉样原纤维的照射效果研究
  • 批准号:
    20K12483
  • 财政年份:
    2020
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
  • 批准号:
    10055342
  • 财政年份:
    2020
  • 资助金额:
    $ 24.81万
  • 项目类别:
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
  • 批准号:
    10188483
  • 财政年份:
    2020
  • 资助金额:
    $ 24.81万
  • 项目类别:
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
  • 批准号:
    10594460
  • 财政年份:
    2020
  • 资助金额:
    $ 24.81万
  • 项目类别:
Cryo-EM structures of AL amyloid fibrils from human heart
人心脏 AL 淀粉样原纤维的冷冻电镜结构
  • 批准号:
    422469128
  • 财政年份:
    2019
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了